Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FCYV4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,901
Award facts
- Contract value 100% obligated
- $37,901.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $37,901.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/mL syringes. The award, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, carries no set-aside designation, indicating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge facility and will serve as the sole contractor on this engagement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.9 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a comprehensive $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. Xolair is a specialized biologic immunosuppressant medication, consistent with DMS Pharmaceutical Group's established portfolio of branded and generic prescription drugs, biologics, and medical supplies supporting recurring DOD medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FCYV4?
SPE2DR26FCYV4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FCYV4 worth?
The government has obligated $37,901 on SPE2DR26FCYV4.
Is contract SPE2DR26FCYV4 an order under another contract?
Yes. SPE2DR26FCYV4 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCYV4 competed?
The extent of competition for SPE2DR26FCYV4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award